Benefits
Hair Growth Promotion (Mostly Animal Evidence)
The one hair study cited on this page (J Ethnopharmacol 2009) applied a methanol extract topically to pigmented C57BL/6 mice and reported dose-dependent hair growth promotion. A second frequently quoted experiment, comparing a petroleum ether extract with 2% minoxidil on shaved albino rat skin, is not among the references listed on this page. There is no human trial of Eclipta alba for hair in the evidence cited here, so this remains topical, rodent-only and preliminary.
Hepatoprotective Activity
Animal evidence only. Eclipta alba has a long traditional use in India for the liver. The single liver reference on this page is a 2001 study in rats and mice, in which an active fraction of an ethanol leaf extract protected against carbon tetrachloride-induced liver damage. No human study of Eclipta alba and liver outcomes is cited on this page, and none of the references reports a human trial. Nothing here supports use for any liver illness.
Possible Anti-Inflammatory Effects
Wedelolactone (the principal coumestan in Eclipta alba) shows anti-inflammatory activity in vitro via NF-κB inhibition and reduced cytokine production. Clinical translation has not been established in human trials.
Possible 5α-Reductase Inhibition
Eclipta alba extract has been reported in laboratory (in vitro) testing to inhibit 5α-reductase, the enzyme that converts testosterone to dihydrotestosterone (DHT). No such study appears among the references on this page, so treat this as an unreferenced laboratory observation. It offers a plausible mechanism for the traditional hair claims, though human clinical confirmation is absent.
Antimicrobial Properties
Eclipta alba shows in vitro antibacterial and antifungal activity, which has been cited as relevant for dandruff (sometimes caused by Malassezia species). Clinical evidence specifically for dandruff or scalp conditions is limited.
Mechanism of action
Hair Cycle Modulation
Eclipta alba extracts induce expression of FGF-7 (KGF) and Sonic hedgehog (Shh) in animal models — both are growth factors that promote anagen-phase entry of hair follicles. They also reduce BMP4 expression, which keeps follicles in telogen (resting) phase. This mechanism explains the observed hair growth promotion in rodent models.
Wedelolactone Bioactivity
Wedelolactone, a coumestan unique to Eclipta and Wedelia genera, is the most-studied bioactive. It inhibits NF-κB, IκB kinase, topoisomerase II, and protein-tyrosine phosphatase 1B. These activities underlie its anti-inflammatory, hepatoprotective, and snake-venom-neutralizing properties documented in preclinical studies.
Antioxidant Activity
Eclipta alba's phenolic constituents (luteolin, apigenin) contribute direct antioxidant activity and induce endogenous antioxidant enzymes via Nrf2 activation. This may underlie hepatoprotective and skin-protective effects.
5α-Reductase Inhibition (Preliminary)
Preliminary laboratory (in vitro) evidence suggests Eclipta alba extract inhibits 5α-reductase, the enzyme that converts testosterone to dihydrotestosterone (DHT), and DHT is involved in age-related hair thinning. None of the references on this page tested this, and human clinical confirmation is absent.
Microcirculation Enhancement
Topical Eclipta alba is reported to enhance scalp microcirculation, increasing nutrient delivery to hair follicles. This is largely a traditional/empirical observation; controlled vasodilatory studies are limited.
Clinical trials
Preclinical study using pigmented C57/BL6 mice in telogen phase. Topical methanol extract of whole-plant Eclipta alba applied to evaluate hair growth promotion. Immunohistochemistry assessed FGF-7, Shh, and BMP4 markers. (Datta, Singh, Mukherjee and colleagues, J Ethnopharmacol 2009, PMID 19481595)
C57/BL6 mice in telogen hair growth phase. Animal model only — no human data.
Methanol extract showed dose-dependent hair growth promotion. Treated animals showed positive FGF-7 and Shh staining (anagen markers) and reduced BMP4 (telogen marker). Authors conclude potential as a hair growth promoter, with mechanism mediated through hair cycle regulatory factors.
Preclinical study, uncited on this page: this rat experiment is not one of the three references listed below, so its details cannot be checked against a source here. As reported, petroleum ether and ethanol extracts of E. alba in an oleaginous cream were applied to shaved albino rat skin, with 2% minoxidil solution as the positive control, and time to hair growth initiation and completion was measured.
Albino rats. Animal model only — no human data.
Hair growth initiation time was significantly reduced to half vs. control with E. alba extract. Time to complete hair growth cycle also significantly reduced. Effects are described as comparable to or better than 2% minoxidil. That comparison comes from a study that is not cited on this page and was measured on shaved rat skin; no comparison of Eclipta alba with minoxidil in people is cited here.
Review of the ethnomedicinal uses, chemical constituents, and biological activities of Eclipta prostrata (synonymous with E. alba). It is a literature review, not a study in people, and it describes no human clinical trial of Eclipta. (Timalsina, Devkota, Biomolecules 2021, PMID 34827736)
Comprehensive literature review across multiple databases.
Documents the traditional applications recorded for Eclipta prostrata across Asian and South American medicine, covering hair, liver, bleeding and skin uses. A review records what has been claimed and studied; it does not confirm that any of these uses works in people. Pharmacological activity reviewed includes hepatoprotection, antimicrobial, anti-inflammatory, and hair growth promotion. Authors note significant phytochemistry/pharmacology progress but limited rigorous human clinical evidence — a recurrent theme in Eclipta research.